Spearhead Capital Advisors, LLC
- SEC CIK
- 0001718982
- Latest filing
- Nov 9, 2022
ACAD holding history
Acadia Pharmaceuticals Inc in every 13F filed by Spearhead Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACAD overviewAll 13F holders of ACADFull Q3 2022 holdings
- Shares (Q1 2022)
- 0
- Sold out in Q1 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2022 | 0 | $0 | 0.0% | −12,929−100.0% | Sold out | Holders |
| Q4 2021 | 12,929 | $302.0K | <0.1% | +300+2.4% | Added | Holders |
| Q3 2021 | 12,629 | $210.0K | <0.1% | −122−1.0% | Reduced | Holders |
| Q2 2021 | 12,751 | $311.0K | <0.1% | +12,751 | New | Holders |